GLTSCR2
Glioma tumor suppressor candidate region gene 2 protein is a protein that in humans is encoded by the GLTSCR2 gene.[1][2][3][4]
References
References
- ↑ Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN, Jenkins RB (Jun 2000). “A transcript map of the chromosome 19q-arm glioma tumor suppressor region”. Genomics. 64 (1): 44–50. doi:10.1006/geno.1999.6101. PMID 10708517.
- ↑ Okahara F, Itoh K, Nakagawara A, Murakami M, Kanaho Y, Maehama T (Oct 2006). “Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation”. Mol Biol Cell. 17 (11): 4888–95. doi:10.1091/mbc.E06-04-0301. PMC 1635402. PMID 16971513.
- ↑ Yim JH, Kim YJ, Ko JH, Cho YE, Kim SM, Kim JY, Lee S, Park JH (Oct 2007). “The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death”. Cell Death Differ. 14 (11): 1872–9. doi:10.1038/sj.cdd.4402204. PMID 17657248.
- ↑ “Entrez Gene: GLTSCR2 glioma tumor suppressor candidate region gene 2”.
Further reading
Further reading
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Bruni R, Fineschi B, Ogle WO, Roizman B (1999). “A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and Is recruited to the nucleus after infection”. J. Virol. 73 (5): 3810–7. PMC 104158. PMID 10196275.
- Andersen JS, Lyon CE, Fox AH, et al. (2002). “Directed proteomic analysis of the human nucleolus”. Curr. Biol. 12 (1): 1–11. doi:10.1016/S0960-9822(01)00650-9. PMID 11790298.
- Scherl A, Couté Y, Déon C, et al. (2003). “Functional proteomic analysis of human nucleolus”. Mol. Biol. Cell. 13 (11): 4100–9. doi:10.1091/mbc.E02-05-0271. PMC 133617. PMID 12429849.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Okahara F, Ikawa H, Kanaho Y, Maehama T (2004). “Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein”. J. Biol. Chem. 279 (44): 45300–3. doi:10.1074/jbc.C400377200. PMID 15355975.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Andersen JS, Lam YW, Leung AK, et al. (2005). “Nucleolar proteome dynamics”. Nature. 433 (7021): 77–83. doi:10.1038/nature03207. PMID 15635413.
- Yim JH, Kim YJ, Cho YE, et al. (2007). “GLTSCR2 sensitizes cells to hypoxic injury without involvement of mitochondrial apoptotic cascades”. Pathobiology. 74 (5): 301–8. doi:10.1159/000105813. PMID 17890897.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH